Researchers in Sweden believe they have created a new form of diagnostic testing that will help identify the potentially fatal cancer Mesothelioma much earlier than is currently possible. The disease, which is caused by exposure to asbestos, has one of the highest fatality rates of any cancer because it is often not diagnosed until it is too late. Asbestos was a widely used building material throughout the 20^th century and the cause of many workplace illnesses or accidents at work.

Mesothelioma is a rare form of cancer that is most commonly found in patients that have endured long term exposure to asbestos material. The fibres of the material are inhaled and cancer forms within the mesothelium, which is a lining that covers many of the organs in the body. Most commonly, mesothelioma is found in the lining of the lungs and the chest wall although it may also be discovered in the lining of the abdominal cavity, the heart, and the testes.

Asbestos was widely used throughout the 20^th century as a building material because it was inexpensive and easy to work with. Even following concerns and scientific findings that pointed to the potential dangers of the material its use continued. Builders and other contractors that came into regular contact with the fibres from the asbestos are those that are at the highest risk of developing mesothelioma. Mesothelioma has become one of the biggest and most significant cases of compensation claims related to illnesses and accidents at work, and cases continue to be brought even today.

Cancer researchers from Sweden tested 565 cases, specifically looking for two of seven biochemical markers. They found the results to not only be highly accurate but to provide a means of identifying mesothelioma in patients sooner and more accurately than using other testing methods. The findings of the study have been published in the PLoS One online journal and they bring hope that the high fatality rate associated with mesothelioma can be reduced.

Employers have a legal obligation to ensure that their employees are provided with a safe working environment. Where employer negligence leads to illnesses and accidents at work, it is possible for the victim to submit a claim for compensation. The amount of compensation awarded to victims does vary, but is typically determined by the type and extent of the injuries or illness that the person suffered. The widespread extent of mesothelioma and the significant damage that it causes patients has seen many millions of pounds in compensation paid to victims of this fatal cancer.

Employees and former employees that believe they were exposed to asbestos can submit compensation claims against their former employers. Where the employer has gone out of business or no longer exists, it is still possible to claim compensation through a government scheme set up for this very purpose. If you, or a relative, have suffered from mesothelioma or any other type of illness or accident at work contact StocksLegal.co.uk on 0800 988 9055 to discuss your options.

MAKING A CLAIM

Making a claim for your personal injuries with Stocks Legal is really easy. You can speak to an experienced personal injury solicitor today by calling 0800 988 9055 or you can use our online claim enquiry form by clicking here. There is no obligation and you have nothing to lose by speaking to us.

ABOUT THE AUTHOR

Mike Topper is the litigation manager at Stocks Legal Personal Injury Solicitors. Mike is highly experienced in all types of personal injury cases. He is highly focussed on client care and getting the maximum compensation that is available for his clients and their families. He rightly sees personal injury claims as a real must for the English legal System as without a proper compensation structure, many injury people can be left with no support or ongoing medical treatment.

If you have any questions arising from this article to can contact Mike by calling 0800 988 9055 or by sending him an email by clicking here.

Access To Justice Accidents At Work Asbestosis Industrial Disease MesotheliomaSep 2nd, 20130 comments